That was the original intent of its designers, to kill off viruses such as hepatitis and HIV.

An adjunct boosts the efficacy of any main therapy. Getting rid of all pathogens that the immune system is handling frees up the immune system, making it easier for any alternative therapy to cure cancer.

In 1991, William Lyman and Steven Kaali of the Albert Einstein College of Medicine designed an electrical device to run on 50 - 100 micro-amps, the equivalent current of a pacemaker.

Lyman and Kaali had it set up to electrify blood in a process similar to dialysis or oxygen therapies that recycle the patient's blood into external machinery. Their device was approved for 14 patents. Just a few articles were published in scientific journals, then silence, but not forever.